The glucagon-like peptide-1 receptor agonist exenatide does not yield improvement in measures of Parkinson disease severity. HealthDay News — The glucagon-like peptide-1 receptor agonist exenatide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback